Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers Medical Dialogues Bureau11 April 2020 1:18 PM ISTNew Delhi: With a recent notification, the Central Government has given powers to the National Pharmaceutical Pricing Authority (NPPA) under the...
Dr Reddy's Labs receives EIR for Nalgonda-based API plant Medical Dialogues Bureau11 April 2020 11:03 AM ISTNew Delhi: Dr Reddy's Laboratories has announced that it has received an establishment inspection report (EIR) from the US health regulator for its...
Jubilant Life Sciences Karnataka plant shut on coronavirus scare Medical Dialogues Bureau8 April 2020 2:15 PM ISTMysuru: The drug-making plant of pharma major Jubilant Life Sciences at Nanjangud near here has been shut down after it was suspected to have been...
USIBC urges govt to ease regulatory curbs on APIs, medical devices Medical Dialogues Bureau30 March 2020 2:58 PM ISTUS-India Business Council has written to Prime Minister Narendra Modi this week to suggested the Centre to "temporarily relax regulatory barriers that...
Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine Medical Dialogues Bureau26 March 2020 1:14 PM ISTKolkata: PSU pharma company Bengal Chemicals and Pharmaceuticals Ltd (BPCL) on Tuesday said it can provide only a maximum of 10 lakh...
Coronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugs Medical Dialogues Bureau23 March 2020 2:31 PM ISTDelhi: With a view to ensure that there is no shortage of medicines in the country with the ongoing Corona crisis, the Prime Minister Shri Narendra...
USFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine Sulphate Medical Dialogues Bureau23 March 2020 1:45 PM ISTMumbai: IPCA Labs has announced that due to the shortage implications and/or medical necessity of certain drugs and finished products, the United...
Cabinet nod to Rs 3000 crore for 3 Bulk Drug parks , Rs 6950 crore Production Linked Incentive Scheme for domestic production of APIs Medical Dialogues Bureau23 March 2020 1:22 PM ISTDelhi: The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, India is significantly...
API should be declared strategic sector especially in light of Coronavirus: CII Medical Dialogues Bureau20 March 2020 11:00 AM ISTNew Delhi: The coronavirus outbreak makes a compelling case for the government to declare active pharmaceutical ingredient (API) as a strategic sector...
Alembic Pharma gets USFDA EIR for API Facility at Karakhadi Medical Dialogues Bureau18 March 2020 12:00 PM ISTGujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages Medical Dialogues Bureau14 March 2020 3:03 PM ISTDelhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that...
NPPA gives a deadline to manufacturers to submit availability data of 58 APIs Medical Dialogues Bureau9 March 2020 1:48 PM ISTNew Delhi: Following with earlier order where the apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) had asked...
